Nasdaq-listed Windtree Therapeutics unveils new funding plans to generate $520 million. Most of the funds will be used to accelerate the firm’s BNB treasury strategy. According to a recent press release, the Nasdaq-listed biotechnology company announced that it has signed…
Related Posts
Web3 is the game changer for athlete monetization beyond the field | Opinion
As the sports industry adopts web3, this will be a fundamental shift transforming how athletes manage their careers…
UK weighs £5 billion Bitcoin sell-off to help plug budget gap
The UK government is reportedly considering plans to sell off over £5 billion worth of seized Bitcoin in…
Starknet’s Quantum Leap hits testnet with TPS reaching ‘triple figures’
Starknet’s latest upgrade will scale the ZK rollup’s throughput by 50X or more. But capacity is very different…